Long-term weight loss and changes in blood pressure: results of the Trials of Hypertension Prevention, phase II - PubMed
- ️Mon Jan 01 2001
Clinical Trial
. 2001 Jan 2;134(1):1-11.
doi: 10.7326/0003-4819-134-1-200101020-00007.
E Obarzanek, N R Cook, I M Lee, L J Appel, D Smith West, N C Milas, M Mattfeldt-Beman, L Belden, C Bragg, M Millstone, J Raczynski, A Brewer, B Singh, J Cohen; Trials for the Hypertension Prevention Research Group
Affiliations
- PMID: 11187414
- DOI: 10.7326/0003-4819-134-1-200101020-00007
Clinical Trial
Long-term weight loss and changes in blood pressure: results of the Trials of Hypertension Prevention, phase II
V J Stevens et al. Ann Intern Med. 2001.
Abstract
Background: Weight loss appears to be an effective method for primary prevention of hypertension. However, the long-term effects of weight loss on blood pressure have not been extensively studied.
Objective: To present detailed results from the weight loss arm of Trials of Hypertension Prevention (TOHP) II.
Design: Multicenter, randomized dinical trial testing the efficacy of lifestyle interventions for reducing blood pressure over 3 to 4 years. Participants in TOHP II were randomly assigned to one of four groups. This report focuses only on participants assigned to the weight loss (n = 595) and usual care control (n = 596) groups.
Patients: Men and women 30 to 54 years of age who had nonmedicated diastolic blood pressure of 83 to 89 mm Hg and systolic blood pressure less than 140 mm Hg and were 110% to 165% of their ideal body weight at baseline.
Intervention: The weight loss intervention included a 3-year program of group meetings and individual counseling focused on dietary change, physical activity, and social support
Measurements: Weight and blood pressure data were collected every 6 months by staff who were blinded to treatment assignment
Results: Mean weight change from baseline in the intervention group was -4.4 kg at 6 months, -2.0 kg at 18 months, and -0.2 kg at 36 months. Mean weight change in the control group at the same time points was 0.1, 0.7, and 1.8 kg. Blood pressure was significantly lower in the intervention group than in the control group at 6, 18, and 36 months. The risk ratio for hypertension in the intervention group was 0.58 (95% CI, 0.36 to 0.94) at 6 months, 0.78 (CI, 0.62 to 1.00) at 18 months, and 0.81 (CI, 0.70 to 0.95) at 36 months. In subgroup analyses, intervention participants who lost at least 4.5 kg at 6 months and maintained this weight reduction for the next 30 months had the greatest reduction in blood pressure and a relative risk for hypertension of 0.35 (CI, 0.20 to 0.59).
Conclusions: Clinically significant long-term reductions in blood pressure and reduced risk for hypertension can be achieved with even modest weight loss.
Comment in
-
Obesity and hypertension: what should we do?
Pickering TG. Pickering TG. Ann Intern Med. 2001 Jan 2;134(1):72-4. doi: 10.7326/0003-4819-134-1-200101020-00016. Ann Intern Med. 2001. PMID: 11187422 No abstract available.
Similar articles
-
Patnode CD, Evans CV, Senger CA, Redmond N, Lin JS. Patnode CD, et al. Rockville (MD): Agency for Healthcare Research and Quality (US); 2017 Jul. Report No.: 15-05222-EF-1. Rockville (MD): Agency for Healthcare Research and Quality (US); 2017 Jul. Report No.: 15-05222-EF-1. PMID: 29364620 Free Books & Documents. Review.
-
Stevens VJ, Corrigan SA, Obarzanek E, Bernauer E, Cook NR, Hebert P, Mattfeldt-Beman M, Oberman A, Sugars C, Dalcin AT, et al. Stevens VJ, et al. Arch Intern Med. 1993 Apr 12;153(7):849-58. Arch Intern Med. 1993. PMID: 8466377 Clinical Trial.
-
Hebert PR, Bolt RJ, Borhani NO, Cook NR, Cohen JD, Cutler JA, Hollis JF, Kuller LH, Lasser NL, Oberman A, et al. Hebert PR, et al. Ann Epidemiol. 1995 Mar;5(2):130-9. doi: 10.1016/1047-2797(94)00057-z. Ann Epidemiol. 1995. PMID: 7795831 Clinical Trial.
-
LeBlanc EL, Patnode CD, Webber EM, Redmond N, Rushkin M, O’Connor EA. LeBlanc EL, et al. Rockville (MD): Agency for Healthcare Research and Quality (US); 2018 Sep. Report No.: 18-05239-EF-1. Rockville (MD): Agency for Healthcare Research and Quality (US); 2018 Sep. Report No.: 18-05239-EF-1. PMID: 30354042 Free Books & Documents. Review.
Cited by
-
Obesity, Adipose Tissue and Vascular Dysfunction.
Koenen M, Hill MA, Cohen P, Sowers JR. Koenen M, et al. Circ Res. 2021 Apr 2;128(7):951-968. doi: 10.1161/CIRCRESAHA.121.318093. Epub 2021 Apr 1. Circ Res. 2021. PMID: 33793327 Free PMC article. Review.
-
Li Y, Feng X, Zhang M, Zhou M, Wang N, Wang L. Li Y, et al. Sci Rep. 2016 Jun 9;6:27627. doi: 10.1038/srep27627. Sci Rep. 2016. PMID: 27279273 Free PMC article.
-
Myers VH, McVay MA, Champagne CM, Hollis JF, Coughlin JW, Funk KL, Gullion CM, Jerome GJ, Loria CM, Samuel-Hodge CD, Stevens VJ, Svetkey LP, Brantley PJ. Myers VH, et al. J Behav Med. 2013 Dec;36(6):574-82. doi: 10.1007/s10865-012-9450-0. Epub 2012 Aug 21. J Behav Med. 2013. PMID: 22907176 Free PMC article. Clinical Trial.
-
Look AHEAD Research Group; Gregg EW, Jakicic JM, Blackburn G, Bloomquist P, Bray GA, Clark JM, Coday M, Curtis JM, Egan C, Evans M, Foreyt J, Foster G, Hazuda HP, Hill JO, Horton ES, Hubbard VS, Jeffery RW, Johnson KC, Kitabchi AE, Knowler WC, Kriska A, Lang W, Lewis CE, Montez MG, Nathan DM, Neiberg RH, Patricio J, Peters A, Pi-Sunyer X, Pownall H, Redmon B, Regensteiner J, Rejeski J, Ribisl PM, Safford M, Stewart K, Trence D, Wadden TA, Wing RR, Yanovski SZ. Look AHEAD Research Group, et al. Lancet Diabetes Endocrinol. 2016 Nov;4(11):913-921. doi: 10.1016/S2213-8587(16)30162-0. Epub 2016 Aug 30. Lancet Diabetes Endocrinol. 2016. PMID: 27595918 Free PMC article. Clinical Trial.
-
Device-guided breathing to lower blood pressure: case report and clinical overview.
Elliott WJ, Izzo JL Jr. Elliott WJ, et al. MedGenMed. 2006 Aug 1;8(3):23. MedGenMed. 2006. PMID: 17406163 Free PMC article.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical